Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Zentralblatt Fur Chirurgie|July 17, 2003
[Experiences after 150 cartilage-bone-transplantations of the knee: a prospective analysis of the results]C Liebau, A W Baltzer, J Arnold, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 17, 2019
Enzyme Replacement Therapy Clears Gb3 Deposits from a Podocyte Cell Culture Model of Fabry Disease but Fails to Restore Altered Cellular SignalingFabian Braun, Linda Blomberg, Susanne Brodesser, et al.
The Journal of Biological Chemistry|June 2, 2012
The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate β-catenin signalingLori Borgal, Sandra Habbig, Julia Hatzold, et al.
Frontiers in Pediatrics|June 20, 2018
Gastrostomy Tube Insertion in Pediatric Patients With Autosomal Recessive Polycystic Kidney Disease (ARPKD): Current PracticeKathrin Burgmaier, Joy Brandt, Rukshana Shroff, et al.
Emerging Infectious Diseases|August 21, 2020
Toxigenic Corynebacterium diphtheriae-Associated Genital UlcerationFrieder Fuchs, Derya Markert, Isabel V Wagner, et al.
American Journal of Physiology. Renal Physiology|July 25, 2025
The nephronophthisis protein GLIS2/NPHP7 is required for the DNA damage response in kidney tubular epithelial cellsLena K Ebert, Lukas Schloesser, Laura E Frech, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 6, 2019
IL-6/Smad2 signaling mediates acute kidney injury and regeneration in a murine model of neonatal hyperoxiaJasmine Mohr, Jenny Voggel, Christina Vohlen, et al.
BMC Nephrology|February 14, 2023
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney diseaseDjalila Mekahli, Max C Liebau, Melissa A Cadnapaphornchai, et al.
Pageof 7